i5np
Nucleic acidexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2007 (NCT00554359)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Cellular tumor antigen p53ANTISENSE INHIBITOR
TP53 antisense inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- i5np
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00802347 | Phase 1/Phase 2 (Phase 2) | Dec 1, 2008 | Quark Pharmaceuticals |
| NCT00683553 | Phase 1 | May 1, 2008 | Quark Pharmaceuticals |
| NCT00554359 | Phase 1 | Aug 1, 2007 | Quark Pharmaceuticals |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Quark Pharmaceuticals | For profit | 3 | 3 | 2 | 2007 |
1 organizations
Page 1 / 1